Patient Experience with a Gynecologic Oncology-Initiated Genetic Testing Model for Women with Tubo-Ovarian Cancer

Patient Experience with a Gynecologic Oncology-Initiated Genetic Testing Model for Women with Tubo-Ovarian Cancer

Background: Up to 20% of women diagnosed with tubo-ovarian carcinoma carry a germline pathogenic variant in a cancer-predisposing gene (e.g., <i>BRCA1/BRCA2</i>). Identifying these variants can help to inform eligibility for therapies, guide surveillance and prevention of new primary can...

Full description

Bibliographic Details
Main Authors: Michaela Bercovitch Sadinsky, Joanne Power, Enza Ambrosio, Laura Palma, Xing Zeng, William D. Foulkes, Evan Weber
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Current Oncology
Subjects:
hereditary cancer
genetic counselling
genetic testing
patient experience
mainstreaming
Online Access:https://www.mdpi.com/1718-7729/29/5/288

Internet

https://www.mdpi.com/1718-7729/29/5/288

Similar Items